tiprankstipranks
LTRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLTRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Lantern Pharma generates new class of ADCs with cryptophycin drug-payload
PremiumThe Fly
Lantern Pharma generates new class of ADCs with cryptophycin drug-payload
2M ago
Lantern Pharma receives Orphan Drug Designation from FDA for LP-284
PremiumThe Fly
Lantern Pharma receives Orphan Drug Designation from FDA for LP-284
5M ago
Lantern Pharma receives notice of allowance from USPTO for ATRT treatment
PremiumThe FlyLantern Pharma receives notice of allowance from USPTO for ATRT treatment
8M ago
Lantern Pharma reports Q2 EPS (44c), consensus (43c)
PremiumThe Fly
Lantern Pharma reports Q2 EPS (44c), consensus (43c)
9M ago
Lantern Pharma announces FDA clearance for LP-184 IND
PremiumThe Fly
Lantern Pharma announces FDA clearance for LP-184 IND
11M ago
Lantern Pharma says no exposure to SVB, Signature Bank or Silvergate Capital
PremiumThe FlyLantern Pharma says no exposure to SVB, Signature Bank or Silvergate Capital
1y ago
Lantern announces new data and development focus for LP-100 with PARPi
PremiumThe Fly
Lantern announces new data and development focus for LP-100 with PARPi
1y ago
Lantern forms Starlight Therapeutics to advance therapies for CNS/brain cancers
PremiumThe Fly
Lantern forms Starlight Therapeutics to advance therapies for CNS/brain cancers
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100